First Trust Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

First Trust Advisors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60,105	Closed	-$2.35M	–	2466
2023 Q1	$2.35M	Sell	60,105 -7,150	-11%	-$350K	﹤0.01%	1618
2022 Q4	$3.55M	Buy	+67,255	New	+$3.28M	﹤0.01%	1401
2022 Q2	–	Sell	-9,440	Closed	-$390K	–	2636
2022 Q1	$390K	Sell	9,440 -30,409	-76%	-$1.07M	﹤0.01%	2317
2021 Q4	$1.7M	Buy	+39,849	New	+$1.99M	﹤0.01%	1848
2021 Q2	–	Sell	-32,862	Closed	-$1.66M	–	2560
2021 Q1	$1.66M	Sell	32,862 -9,404	-22%	-$523K	﹤0.01%	1793
2020 Q4	$2.66M	Buy	42,266 +9,713	+30%	+$603K	﹤0.01%	1432
2020 Q3	$2.19M	Buy	+32,553	New	+$1.78M	﹤0.01%	1324

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

First Trust Advisors's SILK Position: Q2 2023 in Review

First Trust Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 60,105 shares — an estimated $2.35M sold.

First Trust Advisors first reported a position in SILK in Q3 2020 and held it in 7 quarters. The position peaked at $3.55M in Q4 2022. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

First Trust Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
First Trust Advisors sold 60,105 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $2.35M.
First Trust Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
First Trust Advisors's Silk Road Medical, Inc. Common Stock position peaked at $3.55M in Q4 2022.
173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on First Trust Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.